133 Patients with recurrent HCV infection and renal dysfunction after liver transplantation have slower fibrosis progression
β Scribed by E. Cholongitas; A. Quaglia; D. Samonakis; G.V. Papatheodoridis; M. Senzolo; C. Triantos; D. Patch; A.P. Dhillon; A.K. Burroughs
- Book ID
- 117374413
- Publisher
- Elsevier Science
- Year
- 2006
- Tongue
- English
- Weight
- 255 KB
- Volume
- 44
- Category
- Article
- ISSN
- 0168-8278
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Virus-specific CD8+ T cells play a major role in antiviral immune defenses; their significance in the transplant setting, however, is unclear. In the present study, we asked whether hepatitis C virus (HCV)-specific CD8+ T cells were detectable in the presence of an immunosuppressive treatment and wh
Recurrent hepatitis C after liver transplantation (LT) is a major problem, since up to 30% of patients develop cirrhosis only 5 years after LT in the absence of antiviral therapy. The aim of this study was to examine the rate of progression of fibrosis and its associated risk factors in patients sub